Cargando…

Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease

BACKGROUND: Sarcopenia is a prognostic factor for patients with liver cirrhosis and hepatocellular carcinoma, and it affects the onset of hepatic encephalopathy. Therefore, the prevention of sarcopenia contributes to the improvement of the prognosis of patients with chronic liver disease (CLD). We f...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohashi, Kazuki, Ishikawa, Toru, Hoshii, Asami, Hokari, Tamaki, Suzuki, Mitsuyuki, Mitobe, Yuta, Yamada, Etsuko, Abeywickrama, Hansani Madushika, Kikuchi, Yuko, Noguchi, Hirohito, Hirosawa, Hiroshi, Koyama, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785279/
https://www.ncbi.nlm.nih.gov/pubmed/31636786
http://dx.doi.org/10.14740/jocmr3978
_version_ 1783457864202846208
author Ohashi, Kazuki
Ishikawa, Toru
Hoshii, Asami
Hokari, Tamaki
Suzuki, Mitsuyuki
Mitobe, Yuta
Yamada, Etsuko
Abeywickrama, Hansani Madushika
Kikuchi, Yuko
Noguchi, Hirohito
Hirosawa, Hiroshi
Koyama, Yu
author_facet Ohashi, Kazuki
Ishikawa, Toru
Hoshii, Asami
Hokari, Tamaki
Suzuki, Mitsuyuki
Mitobe, Yuta
Yamada, Etsuko
Abeywickrama, Hansani Madushika
Kikuchi, Yuko
Noguchi, Hirohito
Hirosawa, Hiroshi
Koyama, Yu
author_sort Ohashi, Kazuki
collection PubMed
description BACKGROUND: Sarcopenia is a prognostic factor for patients with liver cirrhosis and hepatocellular carcinoma, and it affects the onset of hepatic encephalopathy. Therefore, the prevention of sarcopenia contributes to the improvement of the prognosis of patients with chronic liver disease (CLD). We focused on changes of hand grip strength (HGS), one of the indicators of sarcopenia. However, there are little data investigating the impact of physical activity (PA) on HGS in patients with CLD. This study aimed to clarify whether PA contributes to the prevention of muscle weakness in patients with CLD. METHODS: This was a prospective observational study. We examined the effect of PA on changes in HGS from the baseline to the endpoint in each group. Metabolic equivalents-hour/week (METs-h/w) was used to evaluate PA. In total, 183 outpatients with CLD were analyzed. We divided participants into four groups (low PA in younger patients (n = 20), high PA in younger patients (n = 33), low PA in elderly patients (n = 47), and high PA in elderly patients (n = 83)). RESULTS: Fifty-eight percent of patients were men, and the median (interquartile range) age was 69.0 (63.0, 75.0) years. The most common etiology of liver disease was hepatitis C (38%). The frequency of living alone and low exercise habit was significantly high, and sarcopenia was more obvious in elderly patients with low PA than in those with high PA. Additionally, the elderly with low PA showed significantly reduced HGS compared to that of the elderly with high PA (-1.00 (-2.27, 0.55) kg vs. 0.10 (-1.40, 1.10) kg, P < 0.05). However, changes in HGS in younger patients were not significant (-0.02 (1.83, 1.47) kg vs. 0.25 (-2.45, 2.05) kg, P = 0.96). Logistic regression analyses identified PA as the independent factor for prevention of decrease in HGS (odds ratio: 1.91, 95% confidence interval: 1.00 - 3.62, P = 0.049). CONCLUSIONS: Young patients with low PA were characterized by a long sedentary time; however, there was no loss of HGS. In contrast, elderly patients with CLD and low PA had significantly reduced HGS compared to that in elderly patients with CLD and high PA.
format Online
Article
Text
id pubmed-6785279
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-67852792019-10-21 Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease Ohashi, Kazuki Ishikawa, Toru Hoshii, Asami Hokari, Tamaki Suzuki, Mitsuyuki Mitobe, Yuta Yamada, Etsuko Abeywickrama, Hansani Madushika Kikuchi, Yuko Noguchi, Hirohito Hirosawa, Hiroshi Koyama, Yu J Clin Med Res Original Article BACKGROUND: Sarcopenia is a prognostic factor for patients with liver cirrhosis and hepatocellular carcinoma, and it affects the onset of hepatic encephalopathy. Therefore, the prevention of sarcopenia contributes to the improvement of the prognosis of patients with chronic liver disease (CLD). We focused on changes of hand grip strength (HGS), one of the indicators of sarcopenia. However, there are little data investigating the impact of physical activity (PA) on HGS in patients with CLD. This study aimed to clarify whether PA contributes to the prevention of muscle weakness in patients with CLD. METHODS: This was a prospective observational study. We examined the effect of PA on changes in HGS from the baseline to the endpoint in each group. Metabolic equivalents-hour/week (METs-h/w) was used to evaluate PA. In total, 183 outpatients with CLD were analyzed. We divided participants into four groups (low PA in younger patients (n = 20), high PA in younger patients (n = 33), low PA in elderly patients (n = 47), and high PA in elderly patients (n = 83)). RESULTS: Fifty-eight percent of patients were men, and the median (interquartile range) age was 69.0 (63.0, 75.0) years. The most common etiology of liver disease was hepatitis C (38%). The frequency of living alone and low exercise habit was significantly high, and sarcopenia was more obvious in elderly patients with low PA than in those with high PA. Additionally, the elderly with low PA showed significantly reduced HGS compared to that of the elderly with high PA (-1.00 (-2.27, 0.55) kg vs. 0.10 (-1.40, 1.10) kg, P < 0.05). However, changes in HGS in younger patients were not significant (-0.02 (1.83, 1.47) kg vs. 0.25 (-2.45, 2.05) kg, P = 0.96). Logistic regression analyses identified PA as the independent factor for prevention of decrease in HGS (odds ratio: 1.91, 95% confidence interval: 1.00 - 3.62, P = 0.049). CONCLUSIONS: Young patients with low PA were characterized by a long sedentary time; however, there was no loss of HGS. In contrast, elderly patients with CLD and low PA had significantly reduced HGS compared to that in elderly patients with CLD and high PA. Elmer Press 2019-10 2019-10-04 /pmc/articles/PMC6785279/ /pubmed/31636786 http://dx.doi.org/10.14740/jocmr3978 Text en Copyright 2019, Ohashi et al. http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ohashi, Kazuki
Ishikawa, Toru
Hoshii, Asami
Hokari, Tamaki
Suzuki, Mitsuyuki
Mitobe, Yuta
Yamada, Etsuko
Abeywickrama, Hansani Madushika
Kikuchi, Yuko
Noguchi, Hirohito
Hirosawa, Hiroshi
Koyama, Yu
Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease
title Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease
title_full Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease
title_fullStr Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease
title_full_unstemmed Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease
title_short Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease
title_sort efficacy of physical activity in prevention of muscle weakness in patients with chronic liver disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785279/
https://www.ncbi.nlm.nih.gov/pubmed/31636786
http://dx.doi.org/10.14740/jocmr3978
work_keys_str_mv AT ohashikazuki efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease
AT ishikawatoru efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease
AT hoshiiasami efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease
AT hokaritamaki efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease
AT suzukimitsuyuki efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease
AT mitobeyuta efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease
AT yamadaetsuko efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease
AT abeywickramahansanimadushika efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease
AT kikuchiyuko efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease
AT noguchihirohito efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease
AT hirosawahiroshi efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease
AT koyamayu efficacyofphysicalactivityinpreventionofmuscleweaknessinpatientswithchronicliverdisease